Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
03/2011
03/15/2011CA2397681C Partially saturated calcium channel blockers
03/10/2011WO2011027888A1 Diamide-phenyl derivative and pharmaceutically acceptable salt thereof
03/10/2011WO2011026959A1 Novel ethane diamine hepcidin antagonists
03/10/2011WO2011026781A1 Novel multifunctional peptidase inhibitors, especially for medical use
03/10/2011WO2010063403A3 Radioisotope-labeled lysine and ornithine derivatives, their use and processes for their preparation
03/10/2011WO2009130735A8 Fatty acid derivatives for oral administration endowed with high palatability
03/10/2011US20110059967 Therapeutic compounds
03/10/2011US20110059018 Covalently binding imaging probes
03/10/2011CA2772975A1 Novel multifunctional peptidase inhibitors, especially for medical use
03/09/2011EP2292630A1 O2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates
03/09/2011EP2292595A1 Potassium channel modulators
03/09/2011EP2292589A1 Novel multifunctional peptidase inhibitors, especially for medical use
03/09/2011EP2291353A1 Therapeutic prostaglandin compounds used as ocular hypotensive agents
03/09/2011EP1971585B1 Process for the preparation of a pharmaceutical intermediate
03/09/2011EP1442031B1 Method for producing polyphosphates of organic bases
03/09/2011EP1095128B2 Amine reaction compounds comprising one or more active ingredient
03/08/2011US7902372 Therapy for obesity; using a secondary amino compound
03/08/2011US7902357 Process for the preparation of delmopinol and derivatives thereof
03/08/2011US7902355 Process for the preparation of an 11-(4-substituted-1-piperazinyl)dibenzo[b,f][1,4]thiazepine derivative
03/08/2011US7902191 Histamine H3 receptor antagonists, preparation and therapeutic uses
03/08/2011CA2420899C Hydroxamate derivatives useful as deacetylase inhibitors
03/08/2011CA2415396C 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
03/03/2011WO2011025545A1 Sphingosine type 1 inhibitors and methods for making and using same
03/03/2011WO2011024988A1 Ionic liquid containing allylsulfonate anion
03/03/2011WO2011024557A1 Novel compound, process for preparation thereof, radiation -sensitive compositions containing the novel compound, and cured films
03/03/2011WO2011024079A2 New peptoid agonists of nerve growth factor receptor and their use as medicaments
03/03/2011WO2011023667A1 Carbocyclic glyt1 receptor antagonists
03/03/2011WO2008078200A3 Benzenesulfonamide derivatives as hiv protease inhibitors
03/03/2011US20110054167 Method for producing an amine
03/03/2011US20110053957 Malonate salt of 4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and uses of same
03/03/2011US20110053925 Hydroxamate-Based Inhibitors of Deacetylases
03/03/2011US20110053904 Carbocyclic glyt1 receptor antagonists
03/03/2011US20110053858 Heterocyclic peptide ketoamides
03/03/2011US20110053848 Prodrug comprising a drug linker conjugate
03/03/2011US20110052589 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
03/03/2011US20110052492 Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy
03/03/2011CA2793090A1 Sphingosine type 1 inhibitors and methods for making and using same
03/03/2011CA2772386A1 Tetracycline compounds
03/03/2011CA2767901A1 Carbocyclic glyt1 receptor antagonists
03/02/2011EP2289888A2 Epoxycarboxylic acid amides, azides and amino alcohols and processes for preparation of alpha-keto amides by using them
03/02/2011EP2289887A2 Epoxycarboxylic acid amides, azides and amino alcohols and processes for preparation of alpha-keto amides by using them
03/02/2011EP2289886A1 Peptoid agonists of nerve growth factor and their use as medicaments
03/02/2011EP2289871A1 7-substituted tetracycline compounds
03/02/2011EP2288615A1 Selective caspase inhibitors and uses thereof
03/02/2011EP2046748B1 Phenylpentadienoyl derivatives and their use as par 1 antagonists
03/02/2011EP2004601B1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
03/01/2011US7897764 Thiourea derivatives
03/01/2011US7897623 ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors
03/01/2011US7897601 Cannabinoid receptor modulators
02/2011
02/24/2011WO2011021498A1 (poly) piperazine pyrophosphate powder and manufacturing method therefor
02/24/2011WO2011000945A3 Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns
02/24/2011WO2010129057A8 Tetracycline compounds
02/24/2011US20110046371 Process for preparing 2-(aminomethylidene)-4,4-difluoro-3-oxobutyric esters
02/24/2011US20110046138 Novel compounds advantageous in the treatment of central nervous system diseases and disorders
02/24/2011US20110046129 2-Phenylethylamino Derivatives as Calcium and/or Sodium Channel Modulators
02/24/2011US20110045516 Kits Pertaining to Analyte Determination
02/23/2011EP2285790A1 Therapeutic compounds
02/23/2011EP2035401B1 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
02/23/2011EP1487810B9 4-(diarylmethyl)-1-piperazinyl derivatives
02/23/2011EP1000023B1 Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
02/23/2011CN1419537B Insecticidal anthranilamides
02/23/2011CN101981010A 酰胺化合物 Amide compounds
02/23/2011CN101980767A Aromatic halsulfonyl isocyanate compositions and polymers therefrom
02/23/2011CN101979394A A method to inhibit ethylene responses in plants
02/23/2011CN101979386A Method for preparing cinepazide free alkali
02/22/2011US7893292 Merocyanine derivatives for cosmetic use
02/22/2011US7893266 Detection of cancer cells in vitro using sigma-2 receptor ligands as radiotracers
02/22/2011US7893263 Structural analogs of corosolic acid having anti-diabetic and anti-inflammatory properties
02/22/2011US7893261 bi-functional organic molecules which combine serotonin transporter reuptake inhibition with serotonin (5-HT, such as 5-HT2A) receptor antagonism in one molecular entity
02/22/2011US7893142 Incorporating flame protection agents (reaction product of phosphorous pentoxide and such as guanidine and/or melamine) into plastics; textile finishes
02/22/2011US7893072 Trp-p8 active compounds and therapeutic treatment methods
02/22/2011CA2476296C Amino-derivatives as inhibitors of histone deacetylase
02/22/2011CA2403139C Novel 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and medicaments containing these compounds
02/17/2011WO2011017916A1 Solvatochromic functional monomer and use thereof for chemosensing by solvatochromic molecular imprinting
02/17/2011WO2010123959A3 2,5-disubstituted arylsulfonamide ccr3 antagonists
02/17/2011US20110040105 Processes useful for the synthesis of (r)-1--2-methyl-pyrrolidine
02/17/2011US20110039858 Novel Compounds
02/17/2011US20110039853 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
02/17/2011US20110039852 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
02/17/2011US20110039841 Novel compounds, their preparation and use
02/17/2011US20110039802 Npy y5 antagonist
02/16/2011EP2284152A2 Substituted tetracycline compounds
02/16/2011EP2284150A2 Substituted tetracycline compounds
02/16/2011EP1615866B1 Indene derivatives as pharmaceutical agents
02/16/2011EP1379498B1 Sulphones which modulate the action of gamma secretase
02/16/2011CN1960727B Naphthalene derivatives useful as histamine-3-receptor ligands
02/16/2011CN101974112A Macromolecular bifunctional amino ketone photoinitiator and preparation method thereof
02/16/2011CN101973965A Preparation method of maleic acid cinepazide
02/16/2011CN101973964A Method for separating and extracting 2,2-dimorpholinyl diethyl ether from high-boiling morpholine residues
02/16/2011CN101973963A Method for synthesizing 2, 2-dimorpholinyl diethyl ether by taking high-boiling morpholine as raw material
02/16/2011CN101973829A Trifluoromethylation of trifluoromethyl aryl sulfonium salt to heterocyclic compound under metal trigger
02/16/2011CN101100416B Small molecule inhibitor for preventing Alzheimer's disease Abeta polypeptide from fiberizing and its preparation method, pharmaceutical composition and application
02/15/2011US7888398 chlorinated subphthalocyanine coordinated with boron trichloride; ink for color filter; blue-colored pixels of excellent lightfastness, solvent resistance and heat resistance; brightnesss; saturation; kneading with alcohol solvent and inorganic salt (NaCl): narrow particle size distribution
02/15/2011US7888351 Organic compounds
02/15/2011CA2496842C Heterocyclic aromatic compounds useful as growth hormone secretagogues
02/15/2011CA2476996C Methods for preventing or treating cardiac arrhythmia
02/15/2011CA2452502C 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-n-methyl-isobutyramide
02/10/2011WO2011016016A1 Processes for the preparation of vardenafil
02/10/2011WO2011015037A1 Antiviral compounds and methods of making and using there of cross reference to related applications
02/10/2011US20110034698 Oxonium And Sulfonium Salts
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 341